Tag: buyout
Popular Articles
Clarion Partners raises €552m for third European sale-leaseback fund, with €1.1bn of investment capacity
Clarion Partners has raised €552m for its third European sale-leaseback fund, giving the real estate investment manager about €1.1bn of investment capacity targeting companies seeking to release capital from operational property assets.
Churchill Asset Management more than doubles junior capital fund to record $1.54bn close
Churchill Asset Management has raised a record $1.54bn for its third junior capital opportunities fund, more than doubling the total secured for its predecessor and coming in well ahead of its original $1bn target.
I Squared Capital raises $3bn for second infrastructure credit strategy, quadrupling predecessor
I Squared Capital has secured $3bn in commitments for its second infrastructure credit strategy, doubling its original $1.5bn target and raising four times as much capital as its predecessor.
Igneo Infrastructure Partners hits €6bn hard cap for fourth European fund just six months...
Igneo Infrastructure Partners has raised €6bn for its fourth European infrastructure fund, beating its €4bn target by 50% and reaching its hard cap just six months after first close.
LGT Capital Partners names secondaries veteran Sascha Gruber CEO; Paganoni steps down after 28...
Swiss alternative investment manager LGT Capital Partners has appointed long-serving executive Sascha Gruber as its next chief executive, succeeding Roberto Paganoni after almost three decades leading the $120bn-plus investment business.
Seaya raises €600m at first close for €1bn European growth fund, opens London office
Spanish venture capital manager Seaya has secured €600m at the first close of its new European growth investment fund in just six months, backed by a €300m commitment previously announced by the European Investment Fund.
Formation Bio raises $600m for debut fund targeting up to 15 clinical-stage drug acquisitions
New York-based pharmaceutical developer Formation Bio has secured $600m in commitments for its first dedicated drug development investment fund, targeting the acquisition of up to 15 clinical-stage medicines over the next five years.
Deal Roundup: Thrive strikes $15.3bn ADT take-private; Stonepeak completes BMO finance acquisition
Thrive Holdings has agreed to acquire US home security provider ADT in a $15.3bn take-private transaction, comprising approximately $7.6bn of equity value and $7.7bn of net debt.
CD&R said to gather $20bn for Fund XIII in six months, twice predecessor’s fundraising...
Clayton, Dubilier & Rice has reportedly gathered about $20bn for its thirteenth flagship buyout fund in just six months, twice the amount raised over a comparable period for its $26bn predecessor in 2023.
BY Venture Partners raises $60m for third fund, expands into Europe with Lisbon office
Dubai-based venture capital firm BY Venture Partners has closed its third fund at $60m, 20% larger than its predecessor, as it expands its European investment operations with a new office in Lisbon.
